Name and surname:
|
doc. RNDr. Tatiana Matáková, PhD.
|
Document type:
|
Research/art/teacher profile of a person
|
The name of the university:
|
Comenius University Bratislava
|
The seat of the university:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
III.a - Occupation-position | III.b - Institution | III.c - Duration |
---|---|---|
Associate Professor | Jessenius Faculty of Medicine in Martin Comenius University in Bratislava | 2017 - |
Head of Department of the Molecular Biological Analysis | Jessenius Faculty of Medicine in Martin, BIOMED | 2016-2020 |
researcher | Jessenius Faculty of Medicine in Martin Comenius University in Bratislava | 1997-2001 |
researcher | Slovak Academy of Sciences, Bratislava | 1989-1997 |
V.1.a - Name of the profile course | V.1.b - Study programme | V.1.c - Degree | V.1.d - Field of study |
---|---|---|---|
Medical Chemistry I | General Medicine | I+II | General Medicine |
Medical Biochemistry II | General Medicine | I+II | General Medicine |
Medical Biochemistry | Dentistry | I+II | Dentristy |
Biochemistry | Nursing | I | Nursing |
Biochemistry | Midwifery | I | Midwifery |
Biochemistry | Public Health | I | Public Health |
Matáková T, Halašová E, Škovierová H, Dzian A, Dobrota D, Škereňová M. DPYD genotype and haplotype analysis and colorectal cancer susceptibility in a case-control study from Slovakia. Gen Physiol Biophys. 2017 Dec;36(5):557-563.
Škereňová M, Halašová E, Matáková T, Jesenská Ľ, Jurečeková J, Šarlinová M, Čierny D, Dobrota D. Low Variability and Stable Frequency of Common Haplotypes of the TP53 Gene Region in Colorectal Cancer Patients in a Slovak Population. Anticancer Res. 2017 Apr;37(4):1901-1907
Matáková T., E. Halašová E, H. Škovierová h, A. Dzian A, D. Dobrota D, M. Škereňová M: DPYD genotype and haplotype analysis and colorectal cancer susceptibility in a case-control study from Slovakia, General Physiology and Biophysics Vol.36, No.5, p.557–563, 2017
Jurečeková J, Drobková H, Šarlinová M, Babušíková E, Kmeťová, M, Matáková T, Kliment J, Halašová E: The Role of Interleukin-6 Polymorphism (rs1800795) in Prostate Cancer Development and Progression; Anticancer Research. 2018; 38, (6):3663-3667.
Škereňová, M, Matáková, T, Halašová, E, Rišková, L, Škorvanová, M. Mištuna, Dobrota, Dušan: Common gene haplotypes of gelatinases and their tissue inhibitors in abdominal aortic aneurysm In: General Physiology and Biophysics. 2020; 39 (1): 37-47
Matáková T, Halašová E, Škovierová H, Dzian A, Dobrota D, Škereňová M. DPYD genotype and haplotype analysis and colorectal cancer susceptibility in a case-control study from Slovakia. Gen Physiol Biophys. 2017 Dec;36(5):557-563.
Škereňová M, Halašová E, Matáková T, Jesenská Ľ, Jurečeková J, Šarlinová M, Čierny D, Dobrota D. Low Variability and Stable Frequency of Common Haplotypes of the TP53 Gene Region in Colorectal Cancer Patients in a Slovak Population. Anticancer Res. 2017 Apr;37(4):1901-1907
Matáková T., E. Halašová E, H. Škovierová h, A. Dzian A, D. Dobrota D, M. Škereňová M: DPYD genotype and haplotype analysis and colorectal cancer susceptibility in a case-control study from Slovakia, General Physiology and Biophysics Vol.36, No.5, p.557–563, 2017
Jurečeková J, Drobková H, Šarlinová M, Babušíková E, Kmeťová, M, Matáková T, Kliment J, Halašová E: The Role of Interleukin-6 Polymorphism (rs1800795) in Prostate Cancer Development and Progression; Anticancer Research. 2018; 38, (6):3663-3667.
Škereňová, M, Matáková, T, Halašová, E, Rišková, L, Škorvanová, M. Mištuna, Dobrota, Dušan: Common gene haplotypes of gelatinases and their tissue inhibitors in abdominal aortic aneurysm In: General Physiology and Biophysics. 2020; 39 (1): 37-47
"Molecular mechanisms of the effect of statins on the inhibition, proliferation and differentiation of selected stem and tumor cells and their application in regenerative medicine", Grant scheme: Research and development projects of the APVV, Implementation period: 07/2016 - 06/2020; extension until 31.12.2020
Management of emergency events related to COVID-19 managed by the Ministry of Health of the Slovak Republic; Grant scheme: "Operational Program Environmental Quality; Implementation period: May 2020 - April 2021
Integrative strategy in the development of personalized medicine for selected malignant tumors and its impact on the quality of life; Grant scheme: Operational Program Integrated Infrastructure 2014 - 2020; Implementation period: 2019- 2023
New possibilities for laboratory diagnostics and massive screening of SARS-Cov-2 and identification of mechanisms of virus behavior in the human body; Grant scheme: Operational Program Integrated Infrastructure 2014 - 2020; Implementation period: 2020- 2023
Strengthening the research and development capacity of the Slovak-Czech cross-border region in the field of plasma technologies for medical use.; Grant scheme: Operational programme: Interreg V-A Slovak Republic – Czech Republic 2014 -2020